Pediatric Insomnia and Neurodevelopmental Disorders
Search documents
Idorsia Ltd (IDRSF) Discusses Positive Phase II Results for Daridorexant in Pediatric Insomnia and Neurodevelopmental Disorders - Slideshow (OTCMKTS:IDRSF) 2026-03-31
Seeking Alpha· 2026-03-31 14:42
Group 1 - The article does not provide any relevant content regarding the company or industry [1]
